
Nov 25 (Reuters) - Best Buy Co Inc BBY.N:
BEST BUY OUTLOOK FY ADJUSTED EPS USD 6.25-6.35
BEST BUY OUTLOOK FY REVENUE USD 41,650-41,950 MILLION
BEST BUY Q3 REVENUE USD 9,672 MILLION VERSUS. IBES ESTIMATE USD 9,559 MILLION
BEST BUY Q3 NET INCOME USD 140 MILLION
BEST BUY Q3 GROSS PROFIT USD 2,248 MILLION
BEST BUY Q3 EPS USD 0.66
BEST BUY Q3 ADJUSTED EPS USD 1.4 VERSUS. IBES ESTIMATE USD 1.29
BEST BUY Q3 OPERATING INCOME USD 198 MILLION
BEST BUY Q3 COMPARABLE SALES GROWTH 2.7%
: DURING Q3 FY26, COMPANY RECORDED PRE-TAX NON-CASH ASSET IMPAIRMENTS OF $192 MILLION RELATED TO BEST BUY HEALTH
BEST BUY OUTLOOK FY COMPARABLE SALES GROWTH 0.5-1.2%
: IMPAIRMENTS RELATED TO BEST BUY HEALTH REFLECT DOWNWARD REVISIONS IN CO'S LONGER-TERM PROJECTIONS
BEST BUY CO: IMPAIRMENTS REFLECT DOWNWARD REVISIONS IN CO'S LONGER-TERM PROJECTIONS IN PART DUE TO PRESSURES IN MEDICAID & MEDICARE ADVANTAGE MARKETS
: CHANGE IN BEST BUY HEALTH'S CUSTOMER BASE DURING QUARTER RESULTED IN IMPAIRMENT REVIEW OF ALL BEST BUY HEALTH ASSETS
: STILL EXPECTS TO SPEND ABOUT $300 MILLION ON SHARE REPURCHASES DURING FY26
FY2026 EARNINGS PER SHARE VIEW $6.26, REVENUE VIEW $41.81 BILLION -- LSEG IBES DATA
Further company coverage: BBY.N